Cargando…

Treatment of Chagas Cardiomyopathy

Chagas' disease (ChD), caused by the protozoa Trypanosoma cruzi (T. cruzi), was discovered and described by the Brazilian physician Carlos Chagas in 1909. After a century of original description, trypanosomiasis still brings much misery to humanity and is classified as a neglected tropical dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botoni, Fernando A., Ribeiro, Antonio Luiz P., Marinho, Carolina Coimbra, Lima, Marcia Maria Oliveira, Nunes, Maria do Carmo Pereira, Rocha, Manoel Otávio C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857751/ https://www.ncbi.nlm.nih.gov/pubmed/24350293 http://dx.doi.org/10.1155/2013/849504

Ejemplares similares

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Analysis of Iron Metabolism in Chronic Chagasic Cardiomyopathy
por: Miranda, Carla Paixão, et al.
Publicado: (2019)

Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
por: Costa, Henrique S, et al.
Publicado: (2018)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
por: Miranda, Carla Paixão, et al.
Publicado: (2014)

Exercise tests in Chagas cardiomyopathy: an overview of functional evaluation, prognostic significance, and current challenges
por: Costa, Henrique Silveira, et al.
Publicado: (2020)

Intestinal permeability evaluation in patients with chronic Chagas heart failure
por: Rodrigues, Angela Braga, et al.
Publicado: (2023)

The metabogenic role of iron in chronic chagasic cardiac failure
por: Miranda, Carla Paixão, et al.
Publicado: (2015)

Effects of Exercise Training on Heart Rate Variability in Chagas Heart Disease
por: Nascimento, Bruno Ramos, et al.
Publicado: (2014)

Heart Rate Recovery in Asymptomatic Patients with Chagas Disease
por: de Alencar, Maria Clara Noman, et al.
Publicado: (2014)

Assessment of Functional Capacity in Chagas Heart Disease by Incremental Shuttle Walk Test and its Relation to Quality-of-Life
por: Costa, Henrique Silveira, et al.
Publicado: (2014)

Determinantes da Capacidade Funcional em Pacientes com Doença de Chagas
por: Silva, Whesley Tanor, et al.
Publicado: (2021)

CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy
por: Costa, Germano Carneiro, et al.
Publicado: (2020)

Determinants of minute ventilation-carbon dioxide production relationship in Chagas cardiomyopathy
por: Oliveira, Lucas Frois Fernandes, et al.
Publicado: (2021)

Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain
por: Santos Junior, Omar Ribeiro, et al.
Publicado: (2019)

Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function
por: Silva, Whesley Tanor, et al.
Publicado: (2020)

Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review
por: Chaves, Ana Thereza, et al.
Publicado: (2022)

Disfunção Microvascular Coronariana: Isso Realmente Importa na Doença de Chagas?
por: Nunes, Maria do Carmo Pereira
Publicado: (2020)

Níveis Séricos do BDNF na Proteção Cardiovascular e em Resposta ao Exercício
por: Miranda, Carla Paixão, et al.
Publicado: (2021)

Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease
por: Sousa, Giovane Rodrigo, et al.
Publicado: (2014)

Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
por: Di Lorenzo Oliveira, Claudia, et al.
Publicado: (2020)

Six-minute walk test and incremental shuttle walk test in the evaluation of functional capacity in Chagas heart disease
por: Costa, Henrique Silveira, et al.
Publicado: (2018)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease
por: Ouarhache, Maryem, et al.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)

Impact of the social context on the prognosis of Chagas disease patients: Multilevel analysis of a Brazilian cohort
por: Ferreira, Ariela Mota, et al.
Publicado: (2020)

Health-Related Quality of Life Reported by Patients With Chagas Disease: A Systematic Review of Qualitative Evidence With GRADE Recommendations
por: Silva, Whesley Tanor, et al.
Publicado: (2022)

The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function
por: Sousa, Giovane R., et al.
Publicado: (2017)

A retrospective study of schistosomiasis-associated pulmonary hypertension from an endemic area in Brazil
por: Botoni, Fernando Antônio, et al.
Publicado: (2019)

Contextual influence on poor self-rated health in patients with Chagas disease: multilevel study
por: Ferreira, Ariela Mota, et al.
Publicado: (2022)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil
por: Ferreira, Ariela Mota, et al.
Publicado: (2016)

Functional antibodies against G-protein coupled receptors in Beagle dogs infected with two different strains of Trypanosoma cruzi
por: Wallukat, Gerd, et al.
Publicado: (2022)

Hospitalizations due to gastrointestinal Chagas disease: National registry
por: Bierrenbach, Ana Luiza, et al.
Publicado: (2022)

Association between Microvolt T-Wave Alternans and Malignant Ventricular Arrhythmias in Chagas Disease
por: Almeida, Bárbara Carolina Silva, et al.
Publicado: (2018)

Pathogenesis of Chagas Cardiomyopathy: Role of Inflammation and Oxidative Stress
por: Machado, Fabiana S., et al.
Publicado: (2013)

Reproducibility of point-of-care cardiac ultrasound in Chagas disease by a non-cardiologist with limited training
por: Kreuser, Lucas Jordan, et al.
Publicado: (2014)

Uso de Estatinas Melhora a Proteção Cardiometabólica Promovida pelo Treinamento Físico em Ambiente Aquático: Um Estudo Clínico Randomizado
por: Miranda, Carla Paixão, et al.
Publicado: (2022)

Editorial: Clinical and Molecular Features of Infectious Cardiomyopathies: Implications for Prevention, Treatment and Management
por: Nunes, Maria do Carmo Pereira, et al.
Publicado: (2022)

Stroke in Chagas disease: from pathophysiology to clinical practice
por: Lage, Thaís Aparecida Reis, et al.
Publicado: (2022)

T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies
por: Neves, Eula G. A., et al.
Publicado: (2022)

Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2adarin6npi0okniem9f2ge3df